Company Filing History:
Years Active: 2025
Title: Jinfa Gu: Innovator in Oncolytic Virus Research
Introduction
Jinfa Gu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of oncolytic viruses for cancer treatment. With a total of 2 patents, his work is paving the way for innovative therapeutic approaches.
Latest Patents
Jinfa Gu's latest patents include groundbreaking research on oncolytic viruses. One of his notable inventions is an oncolytic virus expressing interferon. This invention involves an oncolytic adenovirus that comprises a fusion protein expressing interferon, which is capable of effectively suppressing tumors both in vitro and in vivo. Another significant patent is for an oncolytic virus expressing a PD-1 binding protein. This oncolytic adenovirus includes a fusion protein that expresses a PD-1 single-chain antibody, designed to enhance the immune response against tumors.
Career Highlights
Jinfa Gu is associated with Shanghai Yuansong Biotechnology Co. Ltd., where he continues to advance his research. His work focuses on the intersection of virology and immunology, aiming to develop effective cancer therapies. His innovative approach has garnered attention in the scientific community.
Collaborations
Jinfa Gu collaborates with esteemed colleagues, including Kangjian Zhang and Xianlong Fang. Their combined expertise contributes to the advancement of their research projects and the development of new therapeutic strategies.
Conclusion
Jinfa Gu is a key figure in the field of oncolytic virus research, with a focus on innovative cancer treatments. His patents reflect a commitment to improving therapeutic options for patients. His contributions are vital to the ongoing evolution of biotechnology in medicine.